Effectiveness of subcutaneous tunneling technique in reducing PICC dislodgement and malposition: a pilot multicenter randomized controlled trial
Kategoria artykułu: Original article
Data publikacji: 14 mar 2025
Zakres stron: 145 - 153
Otrzymano: 27 mar 2024
Przyjęty: 04 sie 2024
DOI: https://doi.org/10.2478/fon-2025-0016
Słowa kluczowe
© 2025 Yuan Sheng et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Peripherally inserted central catheters (PICCs) are highly recommended for patients requiring chemotherapy, prolonged parenteral nutrition, and long-term antibiotic therapy due to their safety, convenience, versatility, and cost-effectiveness.1–3 As with other central venous access devices (CVADs), there are some initial problems with PICCs. Approximately 14.4%–61.4% of catheters have complications, which increase patients’ physical burden and lead to improper treatment.4–6
Catheter dislodgement and malposition are common and serious problems associated with long-term indwelling. A catheter moved distally is more likely to cause blockage, thrombosis, and malfunctions, whereas a catheter moved proximally is more likely to cause arrhythmias, cardiac tamponade, and tricuspid valve dysfunction.7 Several approaches have been made to securing PICCs, including sutureless devices, semipermeable transparent dressings, and cyanoacrylate adhesives. However, these measures are estimated to be effective between 85% and 95%, and components should be changed regularly.8–10 A bundled approach may be optional without considering economic costs, but more randomized controlled trials (RCTs) with appropriate sample sizes are needed to confirm it.11
Subcutaneous tunneling is a relatively mature technique that uses either a single puncture with the appropriate needle or a double puncture with a metallic device. As early as 2001, Selby et al.12 first reported the subcutaneous tunneling technique for PICCs placement. After that, two Chinese scholars13,14 independently conducted an RCT study and concluded that tunneled PICCs were more effective in preventing dislodgement and malposition than non-tunneled PICCs. However, the results of a multicenter case-control study15 showed no statistical difference between the two groups (
Differences in the results may be indirectly affected by the catheter material, the number of lumens, or the securement strategies. However, it is confirmed that the catheter can move under certain circumstances, including changes in position, arm movements, changes in chest pressure, etc.16,17 Compared to distal movement, proximal movement has received less attention, possibly due to the application of sutureless devices. Approximately 1–2 cm away from the catheter exit, this device effectively limits PICCs’ proximal movement. However, the clinical practice seems to ignore that a minor proximal movement of PICCs can introduce various bacteria into the blood vessels; distal movement may not cause serious health risks at the same distance. Therefore, a parallel, singleblinded, multicenter, and randomized controlled trial was conducted to evaluate the impact of the subcutaneous tunneling technique on catheter movement.
This study was a parallel, single-blinded, multicenter randomized controlled trial conducted over 6 months. All eligible participants were randomly (1:1 ratio) assigned to an experimental group (tunneled PICCs) or a control group (non-tunneled PICCs). Data were collected at the baseline around catheter placement and on days 1, 7 ± 3, 30 ± 7, 60 ± 7, 90 ± 7, 120 ± 7, 150 ± 7, and 180 ± 7 (if applicable). This study followed the CONSORT checklist18 and was registered on the chictr.org website with the registration number (ChiCTR2100049855).
A 3-center RCT underwent a PICCs placement procedure in outpatient departments between August and December 2021 and was observed until May 2022. This study was conducted in 3 tertiary teaching hospitals in China: Qilu Hospital of Shandong University, Liaocheng People’s Hospital, and Zaozhuang Municipal Hospital. The reference number of the Qilu Hospital of Shandong University Ethics Committee was 2021042, and the subcenters approved the permission for this clinical trial.
Eligible participants who were scheduled for PICC placement were recruited. The inclusion criteria were as follows: (1) aged ≥18 years, (2) conscious and able to understand and communicate in Chinese, (3) scheduled to return to our hospitals for maintenance or able to be contacted regularly via mobile phone, and (4) provided informed consent and participated voluntarily in this study. The following exclusion criteria were used: (1) having other types of central venous catheters, e.g., Centrally Inserted Central Catheters (CICCs), PICCs or CICCs ports, and dialysis catheter; (2) planned catheter dwelling time <7 d or life expectancy <1 month; and (3) lack of complete blood count (CBC) or coagulation action test. The eliminated criteria included: (1) missed two or more data collections for any reason and (2) voluntary withdrawal from trials due to exacerbation of illness or other reasons.
This study adopted a type of block randomization stratified by the center with variable block size. A third-party statistician used SAS 9.3 software (SAS Inc., Cary, N.C., USA) to generate the random allocation sequence, and 1:1 random assignments were sealed in consecutive envelopes. Each hospital had an independent researcher to keep the opaque envelope, and the random allocation sequence was revealed after the patients were registered to enroll in the study. The care providers and participants were not blinded due to differences in wounds and surgical procedures between the two groups. However, data collectors and analysts were blinded to random assignments throughout the study.
All PICCs used in our study were 4Fr, open-ended silicone with a proximal valve (Branden Medical Scientific,Inc., Dezhou, Shandong, China). In the control group, non-tunneled PICCs were inserted into the upper arm using the standard PICCs placement under a Doppler ultrasound device, including the function of ECG and Doppler Ultrasound Guidance devices (ECG-EDUG). In the experimental group, the PICCs were placed using metallic tunneling combined with the standard PICCs placement technique. Specifically, there are 3 points that we need to explain in more detail: (1) As for the distal trimming catheter, we created a tunnel in the opposite direction19 after insertion, which prevented hidden problems associated with failed punctures. (2) Gauze is routinely used to reduce bleeding at the exit site following catheter placement in patients without significant bleeding problems. An octyl cyanoacrylate skin adhesive was used in the experimental group instead of gauze at the vein puncture site to achieve as much blinding as possible between the two groups. (3) During the experimental design stage, the sutureless devices recommended by the latest guideline11 were not adopted because they were not universally and uniformly available in all centers. We used sterile transparent dressings and sterile tape fixation, which was widely practiced in our 3 centers. PICCs insertion follows the SIP protocol20 and hospital policies as much as possible. Table 1 lists other components that are important for the PICC placement.
The key components of PICCs placement.
Follow the principle of the maximum sterile barrier during catheter placement and perform strict hand hygiene before surgery A modified Seldinger technique was used to insert PICCs under ultrasound guidance. The CVR ratio was calculated before catheter placement using the vein diameter at the venipuncture site without a tourniquet After inserting the catheter into the vein, a 12–15 cm tunneler with an end connecting the catheter and another end creates a subcutaneous tunnel from the vein puncture site to the tunnel exit site The tunnel length should be longer than 3 cm in the experimental group The exposure length in both groups is 5–7 cm The catheter exit sites were fixed with 2 cm × 2 cm gauze compression and then covered with a 10 cm × 10 cm sterile transparent dressing. A cross-section of sterile tape was used to affix the catheter and dressing, followed by tape used to secure the film’s lower edge All catheter tips were checked using posteroanterior chest X-ray radiography |
PICCs were maintained according to established guidelines11 and hospital policies by specially trained nurses (sterile gauze was removed after 24 h, dressing changed every 7 d, skin antisepsis with 2% chlorhexidine in alcohol, covered with transparent semipermeable membranes, and flushed and locked with saline only). After maintenance, nurses should strictly confirm the catheter’s position and properly record catheter-related complications in a unified maintenance booklet. To meet regulatory requirements, nurses must sign their names.
We collected information on the patient’s demographics, medical history, laboratory test results, and details related to catheter insertion at the time of catheter placement. After returning to our hospital, patients were screened for asymptomatic catheter-related thrombosis (CRT), followed by an appointment with an ultrasonographer. In addition to CRT, independent researchers assessed other outcomes through catheter maintenance or telephone follow-up, with termination dates of extubation for any reason (e.g., end of treatment, unplanned extubation, death, etc.) or 6 months post-insertion. The follow-up period lasted 6 months because many studies reported that the average catheter dwell time was <6 months.4,5,10,21
Catheter dislodgement and malposition are the primary outcomes. When using PICCs, the catheter does not need to be replaced if it moves <2 cm distally; however, if the catheter moves >4–5 cm distally, it must be removed; if the catheter is in between, the patient should have an X-ray to confirm its position.22 Considering this, we defined distal catheter movement as follows: catheter prolapse ≥2 cm (criterion 1) or catheter prolapse ≥5 cm (criterion 2). A shorter catheter exposure outside the skin indicates that the catheter is moving proximally. This is divided into two grades: catheter movement proximally 0.5–2 cm (grade 1) and catheter movement proximally ≥2 cm (grade 2). As secondary outcomes, we also included CRT and catheter-related infection (CRI), as previous studies had shown significant differences between the groups.13–15 Local infections and central line-associated bloodstream infections (CLAB-SIs) that occur during the indwelling period or within 48 h after catheter removal were included.23 CRT was defined as thrombosis detected by ultrasound occurring in the vein with a catheter, including symptomatic or asymptomatic.11,24
Statistical analysis was conducted using SPSS 25.0 (IMB SPSS Software, Chicago, IL, USA). Continuous variables are expressed as mean and standard deviation (SD), and categorical variables are reported as percentages. Group comparisons were performed using the chi-square test or Fisher’s exact test. The final analysis included all randomly assigned patients; missing data were excluded. The level of statistical significance was set at 0.05.
A total of 630 participants were recruited and randomized between August and December 2021. We excluded 10 patients with failed PICCs insertions (

CONSORT flowchart of study participants.
Abbreviations: CONSORT, consolidated standards of reporting trials; PICCs, peripherally inserted central catheters.
Of the 605 patients, 433 (71.57%) completed treatment, 45 (7.44%) underwent unplanned extubation, 39 (6.45%) died, and only 88 (14.54%) still had PICCs after 180 d. The mean age was 55.87 ± 13.94 years, with 83.0% of the participants being female. A total of 88.1% of patients had cancer, mostly pelvic, breast, or gastrointestinal. A total of 71.4% of the insertion bodies were in the right arm, and 85.3% of the insertion vessels were basilic veins. The average length outside the skin was 6.85 ± 0.61 cm, and most tips were located at T7 (52.7%) and T6 (28.8%). The catheter-to-vein ratio (CVR) at the puncture site of the experimental group was lower than that in the control group (
Demographic and clinical characteristics at baseline.
Characteristics and categories | Experimental group ( |
Control group ( |
||
---|---|---|---|---|
55.71 ± 13.46 | 56.03 ± 14.43 | –0.286 | 0.775 | |
24.19 ± 0.21 | 23.81 ± 3.86 | 1.248 | 0.212 | |
Male | 55 (18.2%) | 48 (15.8%) | 0.602 | 0.438 |
Female | 247 (81.8%) | 255 (84.2%) | ||
Yes | 272 (90.1%) | 261 (86.1%) | 2.225 | 0.136 |
No | 30 (9.9%) | 42 (13.9%) | ||
Head disease | 14 (4.6%) | 12 (4.0%) | 2.202 | 0.9 |
Breast disease | 57 (18.9%) | 69 (22.8%) | ||
Respiratory disease | 17 (5.6%) | 16 (5.3%) | ||
Gastrointestinal disease | 47 (15.6%) | 52 (17.2%) | ||
Pelvic disease | 142 (47.0%) | 129 (42.6%) | ||
Blood disease | 10 (3.3%) | 10 (3.3%) | ||
Others | 15 (5.0%) | 15 (5.0%) | ||
Hypertension | 41 (13.6%) | 52 (17.2%) | 1.495 | 0.221 |
Diabetes | 19 (6.3%) | 24 (7.9%) | 0.608 | 0.435 |
CHD | 6 (2.0%) | 13 (4.3%) | 2.639 | 0.104 |
11 (3.6%) | 12 (4.0%) | 0.042 | 0.838 | |
26 (8.6%) | 24 (7.9%) | 0.095 | 0.758 | |
PLT | 247.77 ± 108.48 | 249.94 ± 94.27 | –0.263 | 0.793 |
TT | 14.01 ± 1.69 | 13.78 ± 2.40 | 1.34 | 0.181 |
APTT | 11.47± 1.61 | 11.54± 2.76 | –0.402 | 0.688 |
PT | 30.52 ± 4.67 | 29.66 ± 5.96 | 1.962 | 0.051 |
FIB | 3.47 ± 0.95 | 3.53 ± 1.26 | –0.687 | 0.492 |
D–dimer | 1.13 ± 3.36 | 0.93 ± 1.72 | 0.897 | 0.37 |
Left | 87 (28.8%) | 86 (28.4%) | 0.013 | 0.908 |
Right | 215 (71.2%) | 217 (71.6%) | ||
Basilic vein | 248 (82.1%) | 268 (88.4%) | 4.86 | 0.088 |
Brachial vein | 47 (15.6%) | 30 (9.9%) | ||
Cephalic vein | 7 (2.3%) | 5 (1.7%) | ||
0.28 (0.26, 0.31) | 0.34 (0.30, 0.43) | –11.224 | <0.001 | |
6.84 ± 0.65 | 6.85 ± 0.57 | –0.077 | 0.939 | |
T5 | 9 (3.0%) | 16 (5.3%) | 2.64 | 0.451 |
T6 | 92 (30.5%) | 82 (27.1%) | ||
T7 | 159 (52.6%) | 160 (52.8%) | ||
T8 | 42 (13.9%) | 45 (14.9%) |
Figure 2 shows the average movement length of PICCs outside the skin. The solid line records the mean distal or proximal movement of the catheter using a scalar (has size but no direction), while the dotted line uses a vector (has both size and direction). The average movement lengths increased with time in both groups, but the changes in the control group were more significant than in the experimental group. Notably, a temporal turning point appeared in the control group at 60 ± 7 d. The vertical distance between the solid and dotted lines in the control group was more significant than in the experimental group.

Average movement length of exposed PICCs in both groups.
As shown in Table 3, the results showed opposite characteristics when different criteria determined distal catheter movement, but neither group of results was statistically significant (
Outcomes of the participants.
Characteristics and category | Experimental group ( |
Control group ( |
χ2 | |
---|---|---|---|---|
1.321 | 0.25 | |||
0–2 cm | 251 (83.1%) | 262 (86.5%) | ||
≥2 cm | 51 (16.9%) | 41 (13.5%) | ||
1.327 | 0.249 | |||
0–5 cm | 291 (96.4%) | 286 (94.4%) | ||
≥5 cm | 11 (3.6%) | 17 (5.6%) | ||
Total | 13 (4.3%) | 30 (9.9%) | 7.175 | 0.007 |
0.5–2 cm | 8 (2.6%) | 19 (6.3%) | 7.185 | 0.028 |
≥2 cm | 5 (1.7%) | 11 (3.6%) | ||
Total | 6 (2.0) | 16 (5.3) | 4.683 | 0.03 |
Local infection | 4 (1.3) | 9 (3.0) | 0.101a | |
CLABSI | 2 (0.7) | 7 (2.3) | ||
Total | 11 (3.6) | 38 (12.5) | 16.092 | <0.001 |
Symptomatic | 4 (1.3) | 12 (4.0) | 15.245 | <0.001 |
Asymptomatic | 7 (2.3) | 25 (8.3) |
Experimental/control group 1: Use the scalar ([has size but no direction] to record the average distal or proximal movement of exposed PICCs; Experimental/control group 2: Use the vector (has both size and direction) to record the average distal or proximal movement of exposed PICCs.
PICC-related complications have been compared based on the subcutaneous tunneling technique,15,25–27 but a detailed description of catheter dislodgement and malposition is lacking. Our results showed no significant difference in the incidence of distal catheter movement between the two groups, whether it was the 2 cm or the 5 cm criteria; however, the incidence of proximal catheter movement was significantly reduced in the experimental group, which was reported for the first time. Kim et al.15 reported that this technique was ineffective in reducing distal movement, but the other two studies13,14 reported its significance (
Due to the pressure of tissue compression on catheter securement within the subcutaneous tunnel, tunneled PICCs were shown to minimize freedom of movement and provide fixation of the catheter position.13However, subcutaneous tunneling did not significantly affect the incidence of distal catheter movement. Still, as we increased the criteria from 2 cm to 5 cm, the tunneled PICCs became more advantageous (16.9% vs. 13.5%, 3.6% vs. 5.6%). We believe that there is another explanation for this result. In the formation of subcutaneous tunnels, the catheter may have slight folds or curls, and mild prolapse may occur due to the gravity of the catheter and the pulling force during maintenance. In the middle and late dwelling stages, subcutaneous tunneling became more advantageous for securing PICCs; therefore, it may be more suitable for patients with longterm PICCs needs. Furthermore, tunneled cuffed PICCs may be necessary.28,29 It should be noted, however, that cuffed PICCs were relatively recently introduced, and the safety and efficacy of these devices cannot be compared to the currently prevalent cuffed CICCs. Hence, clinical research is still required to demonstrate their effectiveness.
In this study, the subcutaneous tunneling technique significantly reduced proximal movement (
As mentioned in previous studies,30,31 subcutaneous tunnels form a natural barrier that makes it difficult for microbes to travel retrograde along catheters, thereby reducing the incidence of CRI (
In the experimental group, the incidence of CRT was significantly lower than in the control group (3.6% vs. 12.5%,
At present, tunneled PICCs are not popular in clinical catheterization. However, high rates of CRI and CRT are indeed significant factors affecting the acceptance and promotion of PICCs. This study supports the benefit of subcutaneous tunneling for people with indwelling PICCs in reducing CRI and CRT. Thus, subcutaneous tunneling technology should be promoted in PICCs placement, particularly in patients at high risk of thrombosis and infection. This is the first study that indicates that low CRI and CRT may be related to catheter retraction movement, which may provide a fresh perspective on tunneled PICCs. We encourage more prospective, large-sample, and multicenter studies to explore changes in the incidence of CRI and CRT based on catheter retraction movement, thereby providing more sufficient evidence to support PICC innovation.
Our study explored the effectiveness of the subcutaneous tunneling technique in reducing catheter malposition and dislodgement. This study aimed to explore whether subcutaneous tunneling reduces catheter malposition and dislodgement. Based on the results, the incidence of distal catheter movement was not significantly different between the two groups. This may indicate that cuffed PICCs or sutureless devices are still better for reducing distal catheter movement. However, proximal catheter movement was significantly decreased in the experimental group, which was reported for the first time. In addition, the incidence of CRI and CRT also decreased, possibly as a result of proximal catheter movement. Accordingly, combining subcutaneous tunneling with sutureless devices in cuffed PICCs may be advisable.
This study has several limitations. Firstly, the Infusion Therapy Standards (INS) of Practice 2021 recommend using sutureless devices to secure PICCs. Our experimental design phase did not achieve uniformity across all centers, which needs to be improved. From another perspective, our study demonstrated the necessity of sutureless devices in clinical settings, as the incidence of distal movement was higher than in other studies using sutureless devices.13–15 In light of this, we recommend that hospitals in the same situation introduce sutureless devices as soon as possible. Secondly, catheter movement is significantly affected by insert location.34,35 As a result of factors such as patient position, skin condition, and vascular condition, 50 (16.6%) exit sites in the experimental group and 66 (20.8%) exit sites in the control group were in the red zone, which may increase catheter dislodgement and malposition. However, the comparison between the two groups was not statistically significant (χ2 = 2.665,